MOUNTAIN VIEW, CA--(Marketwired - October 26, 2017) - Fenwick & West today released a first look at results of its Third Quarter 2017 Silicon Valley Venture Capital Survey, which analyzed the terms of 183 venture financings that closed in the third quarter of 2017 by companies headquartered in Silicon Valley. Valuation results substantially increased in Q3 2017 following the modest increases seen in Q1 and Q2 2017. While series B, C and D rounds in Q3 enjoyed larger average valuation increases compared to the prior quarter, later stage Series E+ rounds were up only 19% in Q3 compared to a far greater average increase of 55% in Q2. The life sciences industry notably recorded the strongest valuation results in Q3 2017, in contrast to Q2 when its valuation metrics lagged behind other industries.
